Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/09/08 | N/A | Not yet recruiting | |||
2025/08/08 | Not Applicable | Not yet recruiting | |||
2025/07/22 | Not Applicable | Recruiting | |||
2025/02/04 | N/A | Recruiting | |||
2024/04/02 | Phase 3 | Completed | |||
2024/03/01 | Phase 1 | Completed | |||
2023/04/21 | Phase 3 | Completed | |||
2023/04/14 | Phase 3 | Completed | |||
2023/03/30 | Phase 1 | Completed | |||
2022/06/28 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 5/17/2024 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| AWIQLI insulin icodec 1050 U in 1.5 mL solution for injection pre-filled pen with disposable needles | 440653 | Medicine | A | 6/28/2024 | |
| AWIQLI insulin icodec 1050 U in 1.5 mL solution for injection pre-filled pen | 440652 | Medicine | A | 6/28/2024 | |
| AWIQLI insulin icodec 2100 U in 3 mL solution for injection pre-filled pen with disposable needles | 440651 | Medicine | A | 6/28/2024 | |
| AWIQLI insulin icodec 700 U in 1 mL solution for injection pre-filled pen with disposable needles | 407359 | Medicine | A | 6/28/2024 | |
| AWIQLI insulin icodec 2100 U in 3 mL solution for injection pre-filled pen | 440650 | Medicine | A | 6/28/2024 | |
| AWIQLI insulin icodec 700 U in 1 mL solution for injection pre-filled pen | 407360 | Medicine | A | 6/28/2024 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| AWIQLI | Novo Nordisk Canada Inc | 02546221 | Solution - Subcutaneous | 2100 UNIT / 3 ML | 6/13/2024 |
| AWIQLI | Novo Nordisk Canada Inc | 02546205 | Solution - Subcutaneous | 700 UNIT / ML | 6/13/2024 |
| AWIQLI | Novo Nordisk Canada Inc | 02546213 | Solution - Subcutaneous | 1050 UNIT / 1.5 ML | 6/13/2024 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.